WRLD A.LIVE

23:008 reports

• Cancer-promoting proteins may make tumors easier to spot... but also help them evade immune attack Medical Xpress
• YAP/TAZ protein hyperactivity linked to immune evasion via PD-L2 upregulation Drug Target Review
• Cancer-promoting proteins may make tumors easier to spot but also help them evade immune attack Asia Research News |
• Omega-3 EPA tied to longer survival after liver surgery for bowel cancer spread Bioengineer.org
• Omega-3s Might Improve Survival In Advanced Cancer, Trial Finds U.S. News & World Report
• Subinguinal Orchidectomy for Testicular Tumour: A Regional Analysis of Oncological Control and Postoperative Outcomes Cureus
• Mesothelioma Study Links Asbestos Inflammation to Aggressive Tumor Growth Mesothelioma.net
• Customizable nanoparticles show potential for delivering personalized cancer vaccines Phys.org

22:00nothing heard

21:002 reports

• Orelabrutinib Combo Shows Durable Responses in Relapsed/Refractory CNS Lymphoma CancerNetwork
• A New Era in Pancreatic Cancer Treatment: Daraxonrasib Shakes Up the Landscape OncLive

20:001 report

• Why some “lower-risk” childhood cancers turn deadly Science Daily

19:006 reports

• Cholesterol-sharing mechanism points to potential new target for pancreatic cancer treatment Medical Xpress
• Vitamin C improves survival rate after blood cancer What Doctors Don't Tell You
• Could Oral Vitamin C Confer OS Benefit in CCUS and Lower-Risk MDS? CancerNetwork
• What Nurses Should Tell Patients About Vitamin C in CCUS and MDS Oncology Nursing News
• Activating cancer-fighting protein could make T-cell immunotherapies more effective, study finds UCLA Health
• p53 activation boosts T-cell potency against solid tumours Drug Target Review

18:001 report

• Why some “lower-risk” childhood cancers turn deadly Science Daily

17:002 reports

• Perforin: Michigan researchers find immune protein kills cancer by overloading it with iron Open Access Government
• Platelet hyperactivity drives glioblastoma progression and deep vein thrombosis News-Medical

16:001 report

• Surgeon Recommendations on Thyroidectomy Vary Widely in Low-Risk Thyroid Cancer Medscape

15:00nothing heard

14:002 reports

• KRAS Drug Resistance Has Upstream Cause: METTL13 Enzyme Fuels Tumor Protein Overload Tech Times
• Clinical, Prognostic, and Survival Implications of Vitamin B12 Levels in Cancer Patients Following Chemo- or Radiotherapy Cureus

13:00nothing heard

12:00nothing heard

11:00nothing heard

10:00nothing heard

09:00nothing heard

08:001 report

• Belly fat in young adults linked to higher cancer risk, with women facing steeper odds: study 헤럴드경제

07:001 report

• A protein that regulates mRNA decoding can itself be regulated with implications for understanding cancer Phys.org

06:002 reports

• Newly found enzyme pathway helps cancer cells churn out KRAS growth proteins Bioengineer.org
• Newly Discovered Pathway Fuels Production of Cancer-Driving Proteins | Newswise Newswise

05:003 reports

• What Does ‘In Clinical Trial’ Actually Mean? – Ovarian Cancer Research Foundation Oncodaily
• Residential fine particulate matter linked to minimal residual disease in pediatric leukemia Medical Xpress
• Shifts Seen in Real-world DOAC Use for Cancer-Associated VTE TCTMD.com

04:001 report

• Immune system protein is a cancer killer on its own, new study shows Medical Xpress

03:007 reports

• Obesity in Young Adults Associated with Higher Risk for Early-Onset Cancer | Newswise Newswise
• Obesity In Young Adulthood Linked To Increased Risk Of Early-Onset Cancer U.S. News & World Report
• Adults in their 20s and 30s with severe obesity: 1 in 38 diagnosed with cancer within 10 years... ‘Belly fat’ riskier than BMI 스포츠조선
• Obesity in Young Adulthood Linked to Higher Cancer Risk Into Midlife Pharmacy Times
• Growth Hormone Peptide in Oncology: Clinical Evaluation of Safety EMJ
• METTL13 helps cancer cells produce proteins for tumor growth — News-Medical UA.NEWS
• New study identifies potential targets for KRAS-related treatment resistance News-Medical

02:009 reports

• FDA Approves Rasonque for Previously Treated Advanced Pancreatic Cancer Denkstrom
• Oral Pan-RAS Inhibitors: What’s Next for Pancreatic Cancer Treatment? GeneOnline
• Shubham Pant: What’s Next in Pancreatic Cancer? Oncodaily
• PanCAN Marks Pancreatic Cancer Awareness Month with New Hope as Breakthroughs in Treatments Signal a New Era for Patients Pancreatic Cancer Action Network
• Prior Regimen Did Not Affect Daraxonrasib Benefit in Pretreated Pancreatic Cancer CancerNetwork
• Study identifies translation regulation mechanisms involved in cancer development and treatment resistance | Newswise Newswise
• Methylated eEF1A selectively decodes mRNA to shape cancer proteomes Nature
• Newly discovered pathway fuels production of cancer-driving proteins UT MD Anderson
• New mechanism helps cancer cells selectively produce proteins that drive tumor growth News-Medical

01:00nothing heard

00:001 report

• A bioinformatic resource for pan-cancer proteomics research News-Medical